Timothy James Hobday, MD

  • 5141 Citations
  • 29 Scopus h-Index
19942018

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

  • 5141 Citations
  • 29 Scopus h-Index
  • 48 Article
  • 9 Review article
  • 2 Chapter
  • 2 Letter
2018

Associations between self-reported diet during treatment and chemotherapy-induced peripheral neuropathy in a cooperative group trial (S0221)

Mongiovi, J. M., Zirpoli, G. R., Cannioto, R., Sucheston-Campbell, L. E., Hershman, D. L., Unger, J. M., Moore, H. C. F., Stewart, J. A., Isaacs, C., Hobday, T. J., Salim, M., Hortobagyi, G. N., Gralow, J. R., Thomas Budd, G., Albain, K. S., Ambrosone, C. B. & McCann, S. E., Nov 28 2018, In : Breast Cancer Research. 20, 1, 1077.

Research output: Contribution to journalArticle

1 Scopus citations

Double-blind phase III trial of adjuvant chemotherapy withand without bevacizumab in patients with lymph node-positiveand high-risk lymph node-negative breast cancer (E5103)

Miller, K. D., O'Neill, A., Gradishar, W., Hobday, T. J., Goldstein, L. J., Mayer, I. A., Bloom, S., Brufsky, A. M., Tevaarwerk, A. J., Sparano, J. A., Le-Lindqwister, N. A., Hendricks, C. B., Northfelt, D. W., Dang, C. T. & Sledge, G. W., Sep 1 2018, In : Journal of Clinical Oncology. 36, 25, p. 2621-2629 9 p.

Research output: Contribution to journalArticle

9 Scopus citations

Folate receptor alpha peptide vaccine generates immunity in breast and ovarian cancer patients

Kalli, K. R., Block, M. S., Kasi, P. M., Erskine, C. L., Hobday, T. J., Dietz, A. B., Padley, D., Gustafson, M., Shreeder, B., Puglisi-Knutson, D., Visscher, D. W., Mangskau, T. K., Wilson, G. & Knutson, K. L., Jul 1 2018, In : Clinical Cancer Research. 24, 13, p. 3014-3025 12 p.

Research output: Contribution to journalArticle

15 Scopus citations

Genome-wide meta-analyses identifies novel taxane-induced peripheral neuropathy-associated loci

Sucheston-Campbell, L. E., Clay-Gilmour, A. I., Barlow, W. E., Budd, G. T., Stram, D. O., Haiman, C. A., Sheng, X., Yan, L., Zirpoli, G., Yao, S., Jiang, C., Owzar, K., Hershman, D., Albain, K. S., Hayes, D. F., Moore, H. C., Hobday, T. J., Stewart, J. A., Rizvi, A., Isaacs, C. & 6 others, Salim, M., Gralow, J. R., Hortobagyi, G. N., Livingston, R. B., Kroetz, D. L. & Ambrosone, C. B., Jan 1 2018, In : Pharmacogenetics and Genomics. 28, 2, p. 49-55 7 p.

Research output: Contribution to journalArticle

7 Scopus citations

Health-related quality of life in patients with progressive midgut neuroendocrine tumors treated with 177 lu-dotatate in the phase III netter-1 trial

on behalf of the NETTER-1 Study Group, Sep 1 2018, In : Journal of Clinical Oncology. 36, 25, p. 2578-2584 7 p.

Research output: Contribution to journalArticle

49 Scopus citations

Identification of Factors Associated with Hematology-Oncology Fellow Academic Success and Career Choice

Marshall, A. L., Gupta, R., Grill, D., Mann, S., Freidline, K., Nowakowski, G. S., Thompson, C. A. & Hobday, T. J., Jan 1 2018, (Accepted/In press) In : Journal of Cancer Education.

Research output: Contribution to journalArticle

The influence of tumor stage on the prognostic value of Ki-67 index and mitotic count in small intestinal neuroendocrine tumors

Sun, Y., Lohse, C., Smyrk, T. C., Hobday, T. J., Kroneman, T. & Zhang, L., Jan 1 2018, In : American Journal of Surgical Pathology. 42, 2, p. 247-255 9 p.

Research output: Contribution to journalArticle

5 Scopus citations
2017

Effects of metformin versus placebo on vitamin B12 metabolism in non-diabetic breast cancer patients in CCTG MA.32

From the CCTG, Alliance, SWOG, ECOG, NSABP Cooperative Groups, Jul 1 2017, In : Breast Cancer Research and Treatment. 164, 2, p. 371-378 8 p.

Research output: Contribution to journalArticle

5 Scopus citations

NeoPalAna: Neoadjuvant palbociclib, a cyclin-dependent kinase 4/6 inhibitor, and anastrozole for clinical stage 2 or 3 estrogen receptor–positive breast cancer

Ma, C. X., Gao, F., Luo, J., Northfelt, D. W., Goetz, M. P., Forero, A., Hoog, J., Naughton, M., Ademuyiwa, F., Suresh, R., Anderson, K. S., Margenthaler, J., Aft, R., Hobday, T. J., Moynihan, T., Gillanders, W., Cyr, A., Eberlein, T. J., Hieken, T. J., Krontiras, H. & 14 others, Guo, Z., Lee, M. V., Spies, N. C., Skidmore, Z. L., Griffith, O. L., Griffith, M., Thomas, S., Bumb, C., Vij, K., Huang Bartlett, C., Koehler, M., Al-Kateb, H., Sanati, S. & Ellis, M. J., Aug 1 2017, In : Clinical Cancer Research. 23, 15, p. 4055-4065 11 p.

Research output: Contribution to journalArticle

88 Scopus citations

North Central Cancer Treatment Group N0543 (Alliance): A phase 2 trial of pharmacogenetic-based dosing of irinotecan, oxaliplatin, and capecitabine as first-line therapy for patients with advanced small bowel adenocarcinoma

Mc Williams, R. R., Foster, N. R., Mahoney, M. R., Smyrk, T. C., Murray, J. A., Ames, M. M., Horvath, L. E., Schneider, D. J., Hobday, T. J., Jatoi, A., Meyers, J. P. & Goetz, M. P., 2017, (Accepted/In press) In : Cancer.

Research output: Contribution to journalArticle

14 Scopus citations

Phase 3 trial of 177lu-dotatate for midgut neuroendocrine tumors

Strosberg, J., El-Haddad, G., Wolin, E., Hendifar, A., Yao, J., Chasen, B., Mittra, E., Kunz, P. L., Kulke, M. H., Jacene, H., Bushnell, D., O'Dorisio, T. M., Baum, R. P., Kulkarni, H. R., Caplin, M., Lebtahi, R., Hobday, T., Delpassand, E., Van Cutsem, E., Benson, A. & 15 others, Srirajaskanthan, R., Pavel, M., Mora, J., Berlin, J., Grande, E., Reed, N., Seregni, E., Öberg, K., Sierra, M. L., Santoro, P., Thevenet, T., Erion, J. L., Ruszniewski, P., Kwekkeboom, D. & Krenning, E., Jan 12 2017, In : New England Journal of Medicine. 376, 2, p. 125-135 11 p.

Research output: Contribution to journalArticle

659 Scopus citations

Supplement Use and Chemotherapy-Induced Peripheral Neuropathy in a Cooperative Group Trial (S0221): The DELCaP Study

Zirpoli, G. R., McCann, S. E., Sucheston-Campbell, L. E., Hershman, D. L., Ciupak, G., Davis, W., Unger, J. M., Moore, H. C. F., Stewart, J. A., Isaacs, C., Hobday, T. J., Salim, M., Hortobagyi, G. N., Gralow, J. R., Budd, G. T., Albain, K. S. & Ambrosone, C. B., Dec 1 2017, In : Journal of the National Cancer Institute. 109, 12

Research output: Contribution to journalArticle

Open Access
9 Scopus citations
2016

Everolimus for the treatment of advanced pancreatic neuroendocrine tumors: Overall survival and circulating biomarkers from the randomized, Phase III RADIANT-3 study

Yao, J. C., Pavel, M., Lombard-Bohas, C., Van Cutsem, E., Voi, M., Brandt, U., He, W., Chen, D., Capdevila, J., De Vries, E. G. E., Tomassetti, P., Hobday, T., Pommier, R. & Öberg, K., Nov 10 2016, In : Journal of Clinical Oncology. 34, 32, p. 3906-3913 8 p.

Research output: Contribution to journalArticle

86 Scopus citations
2015

Effect of Metformin vs Placebo on weight and metabolic factors in NCIC CTG MA.32

Goodwin, P. J., Parulekar, W. R., Gelmon, K. A., Shepherd, L. E., Ligibel, J. A., Hershman, D. L., Rastogi, P., Mayer, I. A., Hobday, T. J., Lemieux, J., Thompson, A. M., Pritchard, K. I., Whelan, T. J., Mukherjee, S. D., Chalchal, H. I., Oja, C. D., Tonkin, K. S., Bernstein, V., Chen, B. E. & Stambolic, V., Mar 1 2015, In : Journal of the National Cancer Institute. 107, 3, djv006.

Research output: Contribution to journalArticle

39 Scopus citations

Impact of prior chemotherapy use on the efficacy of everolimus in patients with advanced pancreatic neuroendocrine tumors a subgroup analysis of the phase III RADIANT-3 trial

Lombard-Bohas, C., Yao, J. C., Hobday, T., Van Cutsem, E., Wolin, E. M., Panneerselvam, A., Stergiopoulos, S., Shah, M. H., Capdevila, J. & Pommier, R., Jan 1 2015, In : Pancreas. 44, 2, p. 181-189 9 p.

Research output: Contribution to journalArticle

30 Scopus citations

Multicenter phase II trial of temsirolimus and bevacizumab in pancreatic neuroendocrine tumors

Hobday, T. J., Qin, R., Reidy-Lagunes, D., Moore, M. J., Strosberg, J., Kaubisch, A., Shah, M., Kindler, H. L., Lenz, H. J., Chen, H. & Erlichman, C., May 10 2015, In : Journal of Clinical Oncology. 33, 14, p. 1551-1556 6 p.

Research output: Contribution to journalArticle

63 Scopus citations

N0436 (Alliance): A Phase II Trial of Irinotecan With Cetuximab in Patients With Metastatic Breast Cancer Previously Exposed to Anthracycline and/or Taxane-Containing Therapy

Crozier, J. A., Advani, P. P., Laplant, B., Hobday, T. J., Jaslowski, A. J., Moreno Aspitia, A. & Perez, E. A., May 18 2015, (Accepted/In press) In : Clinical Breast Cancer.

Research output: Contribution to journalArticle

17 Scopus citations

Phase II study of lapatinib in combination with trastuzumab in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer: Clinical outcomes and predictive value of early [<sup>18</sup>F]fluorodeoxyglucose positron emission tomography imaging (TBCRC 003)

Lin, N. U., Guo, H., Yap, J. T., Mayer, I. A., Falkson, C. I., Hobday, T. J., Dees, E. C., Richardson, A. L., Nanda, R., Rimawi, M. F., Ryabin, N., Najita, J. S., Barry, W. T., Arteaga, C. L., Wolff, A. C., Krop, I. E., Winer, E. P. & Van Den Abbeele, A. D., Aug 20 2015, In : Journal of Clinical Oncology. 33, 24, p. 2623-2631 9 p.

Research output: Contribution to journalArticle

21 Scopus citations

SWOG S0221: A phase III trial comparing chemotherapy schedules in high-risk early-stage breast cancer

Budd, G. T., Barlow, W. E., Moore, H. C. F., Hobday, T. J., Stewart, J. A., Isaacs, C., Salim, M., Cho, J. K., Rinn, K. J., Albain, K. S., Chew, H. K., Burton, G. V., Moore, T. D., Srkalovic, G., McGregor, B. A., Flaherty, L. E., Livingston, R. B., Lew, D. L., Gralow, J. R. & Hortobagyi, G. N., Jan 1 2015, In : Journal of Clinical Oncology. 33, 1, p. 58-64 7 p.

Research output: Contribution to journalArticle

45 Scopus citations
2014

Fosaprepitant-induced phlebitis: A focus on patients receiving doxorubicin/cyclophosphamide therapy

Leal, A. D., Kadakia, K. C., Looker, S., Hilger, C., Sorgatz, K., Anderson, K., Jacobson, A., Grendahl, D., Seisler, D., Hobday, T. & Loprinzi, C. L., May 2014, In : Supportive Care in Cancer. 22, 5, p. 1313-1317 5 p.

Research output: Contribution to journalArticle

29 Scopus citations

Germline genetic variants in ABCB1, ABCC1 and ALDH1A1, and risk of hematological and gastrointestinal toxicities in a SWOG Phase III trial S0221 for breast cancer

Yao, S., Sucheston, L. E., Zhao, H., Barlow, W. E., Zirpoli, G., Liu, S., Moore, H. C. F., Thomas Budd, G., Hershman, D. L., Davis, W., Ciupak, G. L., Stewart, J. A., Isaacs, C., Hobday, T. J., Salim, M., Hortobagyi, G. N., Gralow, J. R., Livingston, R. B., Albain, K. S., Hayes, D. F. & 1 others, Ambrosone, C. B., Jun 2014, In : Pharmacogenomics Journal. 14, 3, p. 241-247 7 p.

Research output: Contribution to journalArticle

12 Scopus citations

Obesity and risk of esophageal adenocarcinoma and barrett's esophagus: A mendelian randomization study

Mayo Clinic Esophageal Adenocarcinoma and Barrett's Esophagus Registry Consortium, Nov 1 2014, In : Journal of the National Cancer Institute. 106, 11

Research output: Contribution to journalArticle

72 Scopus citations

Phase 2 trial of paclitaxel polyglumex with capecitabine for metastatic breast cancer

Northfelt, D. W., Allred, J. B., Liu, H., Hobday, T. J., Rodacker, M. W., Lyss, A. P., Fitch, T. R. & Perez, E. A., Apr 2014, In : American Journal of Clinical Oncology: Cancer Clinical Trials. 37, 2, p. 167-171 5 p.

Research output: Contribution to journalArticle

18 Scopus citations

Regional differences in breast cancer biomarkers in american indian and alaska native women

Kaur, J. S., Vierkant, R. A., Hobday, T. & Visscher, D., Mar 2014, In : Cancer Epidemiology Biomarkers and Prevention. 23, 3, p. 409-415 7 p.

Research output: Contribution to journalArticle

6 Scopus citations

Risk factors for pancreatic neuroendocrine tumors a clinic-based case-control study

Halfdanarson, T. R., Bamlet, W. R., McWilliams, R. R., Hobday, T. J., Burch, P. A., Rabe, K. G. & Petersen, G. M., Nov 10 2014, In : Pancreas. 43, 8, p. 1219-1222 4 p.

Research output: Contribution to journalArticle

21 Scopus citations
2013

Everolimus plus octreotide long-acting repeatable in patients with colorectal neuroendocrine tumors: A subgroup analysis of the phase III RADIANT-2 study

Castellano, D., Bajetta, E., Panneerselvam, A., Saletan, S., Kocha, W., O'Dorisio, T., Anthony, L. B. & Hobday, T., Feb 1 2013, In : Oncologist. 18, 1, p. 46-53 8 p.

Research output: Contribution to journalArticle

45 Scopus citations

Supplement use during an intergroup clinical trial for breast cancer (S0221)

Zirpoli, G. R., Brennan, P. M., Hong, C. C., McCann, S. E., Ciupak, G., Davis, W., Unger, J. M., Thomas Budd, G., Hershman, D. L., Moore, H. C. F., Stewart, J., Isaacs, C., Hobday, T., Salim, M., Hortobagyi, G. N., Gralow, J. R., Albain, K. S. & Ambrosone, C. B., Feb 1 2013, In : Breast Cancer Research and Treatment. 137, 3, p. 903-913 11 p.

Research output: Contribution to journalArticle

11 Scopus citations
2012

North central cancer treatment group (NCCTG) N0537: Phase II trial of vegf-trap in patients with metastatic breast cancer previously treated with an anthracycline and/or a taxane

Sideras, K., Dueck, A. C., Hobday, T. J., Rowland, K. M., Allred, J. B., Northfelt, D. W., Lingle, W. L., Behrens, R. J., Fitch, T. R., Nikcevich, D. A. & Perez, E. A., Dec 1 2012, In : Clinical breast cancer. 12, 6, p. 387-391 5 p.

Research output: Contribution to journalArticle

13 Scopus citations

TBCRC 001: Randomized phase II study of cetuximab in combination with carboplatin in stage IV triple-negative breast cancer

Carey, L. A., Rugo, H. S., Marcom, P. K., Mayer, E. L., Esteva, F. J., Ma, C. X., Liu, M. C., Storniolo, A. M., Rimawi, M. F., Forero-Torres, A., Wolff, A. C., Hobday, T. J., Ivanova, A., Chiu, W. K., Ferraro, M., Burrows, E., Bernard, P. S., Hoadley, K. A., Perou, C. M. & Winer, E. P., Jul 20 2012, In : Journal of Clinical Oncology. 30, 21, p. 2615-2623 9 p.

Research output: Contribution to journalArticle

295 Scopus citations
2011

Breast medical oncologists' use of standard prognostic factors to predict a 21-gene recurrence score

Kamal, A. H., Loprinzi, C. L., Reynolds, C., Dueck, A. C., Geiger, X. J., Ingle, J. N., Carlson, R. W., Hobday, T. J., Winer, E. P. & Goetz, M. P., Oct 26 2011, In : Oncologist. 16, 10, p. 1359-1366 8 p.

Research output: Contribution to journalArticle

21 Scopus citations

Cytokeratin-19 and Mammaglobin gene expression in circulating tumor cells from metastatic breast cancer patients enrolled in North Central Cancer Treatment Group trials, N0234/336/436/437

Reinholz, M. M., Kitzmann, K. A., Tenner, K., Hillman, D., Dueck, A. C., Hobday, T. J., Northfelt, D. W., Moreno-Aspitia, A., Roy, V., LaPlant, B., Allred, J. B., Stella, P. J., Lingle, W. L. & Perez, E. A., Nov 15 2011, In : Clinical Cancer Research. 17, 22, p. 7183-7193 11 p.

Research output: Contribution to journalArticle

46 Scopus citations

Evaluation of metformin in early breast cancer: A modification of the traditional paradigm for clinical testing of anti-cancer agents

Goodwin, P. J., Stambolic, V., Lemieux, J., Chen, B. E., Parulekar, W. R., Gelmon, K. A., Hershman, D. L., Hobday, T. J., Ligibel, J. A., Mayer, I. A., Pritchard, K. I., Whelan, T. J., Rastogi, P. & Shepherd, L. E., Feb 1 2011, In : Breast Cancer Research and Treatment. 126, 1, p. 215-220 6 p.

Research output: Contribution to journalArticle

155 Scopus citations

Everolimus for advanced pancreatic neuroendocrine tumors

Yao, J. C., Shah, M. H., Ito, T., Bohas, C. L., Wolin, E. M., Van Cutsem, E., Hobday, T. J., Okusaka, T., Capdevila, J., De Vries, E. G. E., Tomassetti, P., Pavel, M. E., Hoosen, S., Haas, T., Lincy, J., Lebwohl, D. & Öberg, K., Feb 10 2011, In : New England Journal of Medicine. 364, 6, p. 514-523 10 p.

Research output: Contribution to journalArticle

1822 Scopus citations

Future directions in the treatment of neuroendocrine tumors: Consensus report of the National Cancer Institute Neuroendocrine Tumor Clinical Trials Planning Meeting

Kulke, M. H., Siu, L. L., Tepper, J. E., Fisher, G., Jaffe, D., Haller, D. G., Ellis, L. M., Benedetti, J. K., Bergsland, E. K., Hobday, T. J., Van Cutsem, E., Pingpank, J., Oberg, K., Cohen, S. J., Posner, M. C. & Yao, J. C., Mar 1 2011, In : Journal of Clinical Oncology. 29, 7, p. 934-943 10 p.

Research output: Contribution to journalArticle

203 Scopus citations

Genetic predictors of taxane-induced neurotoxicity in a SWOG phase III intergroup adjuvant breast cancer treatment trial (S0221)

Sucheston, L. E., Zhao, H., Yao, S., Zirpoli, G., Liu, S., Barlow, W. E., Moore, H. C. F., Thomas Budd, G., Hershman, D. L., Davis, W., Ciupak, G. L., Stewart, J. A., Isaacs, C., Hobday, T. J., Salim, M., Hortobagyi, G. N., Gralow, J. R., Livingston, R. B., Albain, K. S., Hayes, D. F. & 1 others, Ambrosone, C. B., Dec 1 2011, In : Breast Cancer Research and Treatment. 130, 3, p. 993-1002 10 p.

Research output: Contribution to journalArticle

39 Scopus citations

Therapy innovations: Tyrosine kinase inhibitors for the treatment of pancreatic neuroendocrine tumors

Raymond, E., Hobday, T., Castellano, D., Reidy-Lagunes, D., García-Carbonero, R. & Carrato, A., Mar 2011, In : Cancer and Metastasis Reviews. 30, SUPPL. 1, p. S19-S26

Research output: Contribution to journalArticle

26 Scopus citations
2010

Daily oral everolimus activity in patients with metastatic pancreatic neuroendocrine tumors after failure of cytotoxic chemotherapy: A phase II trial

Yao, J. C., Lombard-Bohas, C., Baudin, E., Kvols, L. K., Rougier, P., Ruszniewski, P., Hoosen, S., St. Peter, J., Haas, T., Lebwohl, D., Van Cutsem, E., Kulke, M. H., Hobday, T. J., O'Dorisio, T. M., Shah, M. H., Cadiot, G., Luppi, G., Posey, J. A. & Wiedenmann, B., Jan 1 2010, In : Journal of Clinical Oncology. 28, 1, p. 69-76 8 p.

Research output: Contribution to journalArticle

482 Scopus citations

Medical treatment of neuroendocrine tumors

Hobday, T. J., Dec 1 2010, Endocrine Pathology: Differential Diagnosis and Molecular Advances. Springer New York, p. 561-566 6 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

2009

Carcinoid Syndrome

Halfdanarson, T. R. & Hobday, T. J., Jan 27 2009, Clinical Endocrine Oncology: Second Edition. Blackwell Publishing Ltd, p. 488-497 10 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Long-term survivors of metastatic colorectal cancer treated with systemic chemotherapy alone: A north central cancer treatment group review of 3811 patients, n0144

Dy, G. K., Hobday, T. J., Nelson, G., Windschitl, H. E., O'Connell, M. J., Alberts, S. R., Goldberg, R. M., Nikcevich, D. A. & Sargent, D. J., 2009, In : Clinical colorectal cancer. 8, 2, p. 88-93 6 p.

Research output: Contribution to journalReview article

40 Scopus citations
2008
12 Scopus citations

Medical management of pancreatic neuroendocrine tumors

Delaunoit, T., Neczyporenko, F., Rubin, J., Erlichman, C. & Hobday, T. J., Feb 1 2008, In : American Journal of Gastroenterology. 103, 2, p. 475-483 9 p.

Research output: Contribution to journalReview article

31 Scopus citations

Small steps forward in the land of small tumors

Hobday, T. J. & Pitot, H. C., Dec 1 2008, In : Oncology. 22, 14, p. 1623-1629 7 p.

Research output: Contribution to journalReview article

2007

Can sorafenib cause hypothyroidism? [3]

Robinson, S. I., Hobday, T. J., Sathananthan, A., Morris, J. C. & McWilliams, R. R., Jun 2007, In : Journal of Chemotherapy. 19, 3, p. 352-353 2 p.

Research output: Contribution to journalLetter

4 Scopus citations

Carcinoid Heart Disease

Bernheim, A. M., Connolly, H. M., Hobday, T. J., Abel, M. D. & Pellikka, P. A., May 1 2007, In : Progress in Cardiovascular Diseases. 49, 6, p. 439-451 13 p.

Research output: Contribution to journalArticle

57 Scopus citations

Characterization of the functional and growth properties of cell lines established from ileal and rectal carcinoid tumors

Stilling, G. A., Zhang, H., Ruebel, K. H., Leontovich, A. A., Jin, L., Tanizaki, Y., Zhang, S., Erickson, L. A., Hobday, T. & Lloyd, R. V., Dec 1 2007, In : Endocrine Pathology. 18, 4, p. 223-232 10 p.

Research output: Contribution to journalArticle

12 Scopus citations
2006

A single-center experience with inflammatory breast cancer, 1985-2003

Smoot, R. L., Koch, C. A., Degnim, A. C., Sterioff, S., Donohue, J. H., Grant, C. S., Barnes, S. A., Gullerud, R. E., Hobday, T. J. & Farley, D. R., Jun 27 2006, In : Archives of Surgery. 141, 6, p. 567-572 6 p.

Research output: Contribution to journalArticle

24 Scopus citations

Association of DNA methylation and epigenetic inactivation of RASSF1A and beta-catenin with metastasis in small bowel carcinoid tumors

Zhang, H. Y., Rumilla, K. M., Jin, L., Nakamura, N., Stilling, G. A., Ruebel, K. H., Hobday, T. J., Erlichman, C., Erickson, L. A. & Lloyd, R. V., Dec 1 2006, In : Endocrine. 30, 3, p. 299-306 8 p.

Research output: Contribution to journalArticle

36 Scopus citations

Liver transplantation for gastroenteropancreatic neuroendocrine cancers: Defining selection criteria to improve survival

van Vilsteren, F. G. I., Baskin-Bey, E. S., Nagorney, D. M., Sanderson, S. O., Kremers, W. K., Rosen, C. B., Gores, G. J. & Hobday, T. J., Mar 1 2006, In : Liver Transplantation. 12, 3, p. 448-456 9 p.

Research output: Contribution to journalReview article

104 Scopus citations
2005

An overview of approaches to adjuvant therapy for colorectal cancer in the United States

Hobday, T. J., Apr 2005, In : Clinical colorectal cancer. 5, SUPPL. 1, p. S11-S18

Research output: Contribution to journalArticle

17 Scopus citations